Patent application number | Description | Published |
20100029636 | Lck inhibitors - The invention relates to novel pyrazolo[1,5-A]pyrimidine compounds of Formula I | 02-04-2010 |
20100130469 | 2, 6-NAPHTHRIDINE DERIVATIVES - The present invention relates to novel organic compounds comprising a naphthyridine which may be mediators of a selective subset of kinases belonging to the AGC kinase family, such as for example PKC, PKD, PKN-1/2, CDK-9, MRCK-beat, PASK, PRKX, ROCK-I/II or mediators of other kinases, the selectivity of which would be depending on the structural variation thereof. | 05-27-2010 |
20110172231 | 2,4- DIAMINOPYRIMIDINE DERIVATIVES - There are provided compounds of formula I | 07-14-2011 |
20120142685 | ORGANIC COMPOUNDS - The present invention provides a compound formula I: (formula I) said compound is inhibitor of selective subset of kinases belonging to the AGC or calmodulin kinase family, such as for example MARK1/2/3, PKD-1/2/3, PKN-1/2, CDK-9, CaMKII, ROCK-I/II, inhibitors of histone deacetylase (HDAC) phosphorylation, or inhibitors of other kinases. Finally, the present invention also provides a pharmaceutical composition. | 06-07-2012 |
20130345180 | 2,4- DIAMINOPYRIMIDINE DERIVATIVES - There are provided compounds of formula I | 12-26-2013 |
Patent application number | Description | Published |
20080242675 | Indolylmaleimide Derivatives as Pkc Inhibitors - This invention relates to PKC inhibitors which are able to selectively inhibit e.g. the and optionally 0, isoforms of PKC, and their use in particular in transplantation. | 10-02-2008 |
20090221605 | SUBSTITUTED PYRROLE-2, 5-DIONES AS PROTEIN KINASE C INHIBITORS - A compound of formula I | 09-03-2009 |
20090318463 | Indolylmaleimide Derivatives - Indolylmaleimide derivatives comprising either a substituted phenyl, naphthyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl or pyrimidinyl residue have interesting pharmaceutical properties, e.g. in the treatment and/or prevention of T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer. | 12-24-2009 |
20100041693 | INDOLYLMALEIMIDE DERIVATIVES - A compound of formula (I) | 02-18-2010 |